Page 13 - Pfizer
Biden touts Pfizer booster access after CDC boss overrules panel
The Centers for Disease Control and Prevention director, Rochelle Walensky, issued a statement advising that booster shots could be given to people with the Pfizer vaccine 6 months after second shot
 "Biden touts Pfizer booster access after CDC boss overrules panel")
US FDA okays Covid booster shot for people above 65, or at high-risk
The US Food and Drug Administration (FDA) has authorised booster shots of the Pfizer Covid-19 vaccine for people aged 65 and older or at high-risk
 "US FDA okays Covid booster shot for people above 65, or at high-risk")
US CDC panel endorses Pfizer booster shot for elderly, high-risk people
A US CDC advisory panel on Thursday endorsed booster doses of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with certain high risk conditions
 "US CDC panel endorses Pfizer booster shot for elderly, high-risk people")
EU regulator to decide on Pfizer booster dose at the start of October
Pfizer declined to comment, while BioNTech was not available for comment
US approves third Pfizer dose for people above 65, at-risk Americans
The panel is likely to discuss guidance for physicians on how to administer the third doses
FDA approves older, Covid at-risk people for Pfizer booster shot in US
Booster doses can be given any time at least six months after a person received their second shot, says the agency.
 "FDA approves older, Covid at-risk people for Pfizer booster shot in US")
Joe Biden doubles US global donation of Pfizer Covid-19 vaccine shots
President Joe Biden announced Wednesday that the United States is doubling its purchase of Pfizer's Covid-19 shots to share with the world to 1 billion doses
 "Joe Biden doubles US global donation of Pfizer Covid-19 vaccine shots")
India unlikely to buy Pfizer, Moderna Covid-19 vaccines for now: Sources
India is unlikely to buy Pfizer and Moderna Covid-19 vaccines for now as the domestic manufacturing of anti-coronavirus jabs has picked up pace, sources said
Pfizer Covid-19 vaccine safely bolsters antibodies in younger kids
Drugmaker, partner BioNTech to submit data to US regulators
Top headlines: Evergrande threat hits markets; Pfizer vaccine works on kids
Business Standard brings you the top headlines on Monday
Pfizer vaccine safe for children aged 5-11, show clinical trial results
Pfizer said Monday its Covid-19 vaccine works for children ages 5 to 11 and that it will seek US authorisation for this age group soon -- a key step toward beginning vaccinations for youngsters.
 "Pfizer vaccine safe for children aged 5-11, show clinical trial results")
US FDA panel backs booster shot for elderly, high risk groups
A US FDA advisory panel has endorsed a booster shot of Pfizer-BioNTech Covid-19 vaccine six months after full inoculation in people above 65 years and for individuals at high risk for severe disease
 "US FDA panel backs booster shot for elderly, high risk groups")
FDA advisory panel rejects widespread Pfizer booster shots
An influential federal advisory panel has soundly rejected a plan to offer Pfizer booster shots against Covid-19 to most Americans.
As many remain unvaccinated, debate grows over need for booster Covid shots
Experts say to prevent the coronavirus from morphing into even more dangerous forms than the Delta variant, the more urgent need is to protect the unvaccinated.
 "As many remain unvaccinated, debate grows over need for booster Covid shots")
Pfizer says booster shots of vaccine restore waning immunity
No new unexpected side effects were identified from safety data associated with boosters in the final-stage study
Gennova's mRNA vaccine to come in powder form; will stay stable at 2-8 °C
The lyophilized vaccine will come in a powder form and it will be mixed with diluents before administration
 "Gennova's mRNA vaccine to come in powder form; will stay stable at 2-8 °C")
UK approves Pfizer, AstraZeneca vaccines as booster doses for Covid-19
The UK's health regulator has approved Pfizer and AstraZeneca vaccines for booster doses against Covid-19, even as the country's decision on the third dose remains pending.
80% Covid immunity lost in 6 months in some after Pfizer shot: US study
The researchers particularly looked at humoral immunity - also called antibody-mediated immunity - to measure the body's defences
Pfizer booster likely by September 20, Moderna may be delayed: Fauci
Maryland Governor Larry Hogan, a Republican, criticised the Biden administration for "mixed messaging."
EU regulator evaluating if Covid-19 vaccine booster dose is needed
The European Medicines Agency says it has started an expedited evaluation on whether to recommend a booster dose of the coronavirus vaccine made by Pfizer-BioNTech
 "EU regulator evaluating if Covid-19 vaccine booster dose is needed")